Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity

Autor: Hok-Kiu Lui, Ka-Yan Chow, Fung-Yi Chan, Ning Sun, Siu-Cheong Yan, Ruben Abagyan, Kwok Yin Wong, Yu-Jing Lu, Kin-Fai Chan, Tak Hang Chan, Yong Wang, Yun Chung Leung, Marco A. C. Neves
Přispěvatelé: Scheffers, Dirk-Jan
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Models
Molecular

Berberine
Protein Conformation
lcsh:Medicine
Biochemistry
chemistry.chemical_compound
Models
Drug Discovery
Macromolecular Structure Analysis
Medicine and Health Sciences
lcsh:Science
Microscopy
Multidisciplinary
biology
Molecular Structure
Alkaloid
Gram Positive Bacteria
Antimicrobial
Bacterial Pathogens
Anti-Bacterial Agents
Chemistry
Infectious Diseases
5.1 Pharmaceuticals
Medical Microbiology
Physical Sciences
Development of treatments and therapeutic interventions
Antibacterial activity
Infection
Research Article
Drug Research and Development
General Science & Technology
Microbial Sensitivity Tests
macromolecular substances
Gram-Positive Bacteria
Electron
Microbiology
Bacterial Proteins
Microscopy
Electron
Transmission

Microbial Control
Complementary and Integrative Health
Chemical Biology
Escherichia coli
Transmission
FtsZ
Benzylisoquinoline
Gram Negative Bacteria
Microbial Pathogens
Molecular Biology
Pharmacology
Organic Chemistry
Organic Synthesis
lcsh:R
Rational design
Molecular
Biology and Life Sciences
Computational Biology
Bacteriology
biology.organism_classification
Cytoskeletal Proteins
Emerging Infectious Diseases
chemistry
biology.protein
lcsh:Q
Antimicrobial Resistance
Bacteria
Zdroj: PLoS ONE, Vol 9, Iss 5, p e97514 (2014)
PLoS ONE
PloS one, vol 9, iss 5
ISSN: 1932-6203
Popis: Inhibition of the functional activity of Filamenting temperature-sensitive mutant Z (FtsZ) protein, an essential and highly conserved bacterial cytokinesis protein, is a promising approach for the development of a new class of antibacterial agents. Berberine, a benzylisoquinoline alkaloid widely used in traditional Chinese and native American medicines for its antimicrobial properties, has been recently reported to inhibit FtsZ. Using a combination of in silico structure-based design and in vitro biological assays, 9-phenoxyalkyl berberine derivatives were identified as potent FtsZ inhibitors. Compared to the parent compound berberine, the derivatives showed a significant enhancement of antibacterial activity against clinically relevant bacteria, and an improved potency against the GTPase activity and polymerization of FtsZ. The most potent compound 2 strongly inhibited the proliferation of Gram-positive bacteria, including methicillin-resistant S. aureus and vancomycin-resistant E. faecium, with MIC values between 2 and 4 µg/mL, and was active against the Gram-negative E. coli and K. pneumoniae, with MIC values of 32 and 64 µg/mL respectively. The compound perturbed the formation of cytokinetic Z-ring in E. coli. Also, the compound interfered with in vitro polymerization of S. aureus FtsZ. Taken together, the chemical modification of berberine with 9-phenoxyalkyl substituent groups greatly improved the antibacterial activity via targeting FtsZ.
Databáze: OpenAIRE